September 6, 2017

FDG-PET/CT predicts melanoma patients' response to immune checkpoint inhibitor therapy

Advanced melanoma, a type of skin cancer that has spread to other areas of the body, has a poor prognosis, but immune checkpoint inhibitor therapy can be effective for some patients. Research highlighted in the featured article of the September issue of The Journal of Nuclear Medicine demonstrates that combined positron emission tomography/computed tomography (PET/CT) scanning early in treatment could identify whether the therapy will benefit a particular patient. As the therapy has potentially serious side-effects, early determination of ineffectiveness could avert unnecessary risk exposure and provide the option of a different treatment.  {read more here}

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

CAPTCHA:      = 

Leave a Reply

Your email address will not be published. Required fields are marked *